IOBT Q4 2021 Earnings — IO Biotech, Inc. Revenue & Financial Results | Market Cap Arena

IOBTIO Biotech, Inc.

$21M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$21M

Net Income

-$21M

EPS (Diluted)

$-0.83

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$222M

Total Liabilities

$10M

Stockholders' Equity

$212M

Cash & Equivalents

$212M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$21M	-$3M	-742.7%
Net Income	-$21M	-$3M	-734.3%